Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Lotan

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Oncogenesis|December 17, 2013
Mitochondrial DNA depletion sensitizes cancer cells to PARP inhibitors by translational and post-translational repression of BRCA2A A Arbini, F Guerra, M Greco, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]A Mbeutcha, I Lucca, M De Martino, et al.
The Journal of Urology|October 26, 2019
Reply by AuthorsY Lotan, B A Inman, L G Davis, et al.
Prostate Cancer and Prostatic Diseases|October 15, 2014
Perioperative outcomes and hospital reimbursement by type of radical prostatectomy: results from a privately insured patient populationS P Kim, C P Gross, M C Smaldone, et al.
British Journal of Cancer|August 29, 2013
Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladderE Xylinas, M Kent, L Kluth, et al.
Prostate Cancer and Prostatic Diseases|September 4, 2013
Impact of statin use on biochemical recurrence in patients treated with radical prostatectomyM Rieken, L A Kluth, E Xylinas, et al.
Oncogene|March 4, 2026
Correction: Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapiesJ Zhou, J Luo, K Wu, et al.
World Journal of Urology|October 13, 2016
Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tractG J Wirth, A Haitel, M Moschini, et al.
Oncogene|February 16, 2016
Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapiesJ Zhou, J Luo, K Wu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 12, 2013
Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinomaM Rieken, E Xylinas, L Kluth, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Oncogenesis|December 17, 2013
Mitochondrial DNA depletion sensitizes cancer cells to PARP inhibitors by translational and post-translational repression of BRCA2A A Arbini, F Guerra, M Greco, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]A Mbeutcha, I Lucca, M De Martino, et al.
The Journal of Urology|October 26, 2019
Reply by AuthorsY Lotan, B A Inman, L G Davis, et al.
Prostate Cancer and Prostatic Diseases|October 15, 2014
Perioperative outcomes and hospital reimbursement by type of radical prostatectomy: results from a privately insured patient populationS P Kim, C P Gross, M C Smaldone, et al.
British Journal of Cancer|August 29, 2013
Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladderE Xylinas, M Kent, L Kluth, et al.
Prostate Cancer and Prostatic Diseases|September 4, 2013
Impact of statin use on biochemical recurrence in patients treated with radical prostatectomyM Rieken, L A Kluth, E Xylinas, et al.
Oncogene|March 4, 2026
Correction: Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapiesJ Zhou, J Luo, K Wu, et al.
World Journal of Urology|October 13, 2016
Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tractG J Wirth, A Haitel, M Moschini, et al.
Oncogene|February 16, 2016
Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapiesJ Zhou, J Luo, K Wu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 12, 2013
Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinomaM Rieken, E Xylinas, L Kluth, et al.
Pageof 4